Home

Anti-Aging

Navigation

Anti-Aging » Anti-Aging and Medical Conditions » Cataract » Review News

POSITIVE RESULTS FROM THE PHASE III MARINA STUDY OF THE investigational anti-VEGF drug Lucentis in 716 patients with wet age-related macular degeneration were released last month.

Original Article: Review News

Continue Reading: 1 2 3 4 5

Email This Article

Post Your Comment

Print This Article

Peer Rating System: Would you recommend this article?
No I wouldn't 1 2 3 4 5 Yes I Would
0.00 out of 5, With 0 Votes

Category Articles

Should hospitalized patients be routinely screened for MRSA?
Defensive medicine wastes money and hurts patients
America's unhealthiest city
Poll: Top health care issues you will face in 2009 as a practici
How Motrin angered mothers and underestimated the Twitter respon
Resident physicians, medicine's last hope?
New reader welcome
How Boston's top hospitals are paid much more
ReachMD Poll: Top health care issues you will face in 2009 as a
Strengthen visual spacialization with a 3-D MRI block puzzle

Nav: [ 1 2 3 4 5 >> ]

Site Tree | Disclaimer
Link Index | Resources | More Resources

What is Anti-Aging, Anti-Ageing or Antiaging?

Home

Anti-Aging

Anti-Aging Information Partners

Anti-Aging Conferences

Anti-Aging Books

Anti-Aging Extras

Syndicate

Tools

No I wouldn't 1 2 3 4 5 Yes I Would

What is Anti-Aging, Anti-Ageing or Antiaging?

We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)